CA
NZ
UK
AU
IND
US
…
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | 200.72M | 518.50M | 484.80M | 396.60M | 393.80M |
| Net income | 147.09M | 388.90M | 356.80M | 300.60M | 289.10M |
| Selling general administrative | 1022.50M | 207.90M | 212.60M | 203.90M | 159.00M |
| Selling and marketing expenses | - | 732.00M | 685.00M | 606.50M | 498.70M |
| Gross profit | 1644.39M | 1727.90M | 1673.50M | 1448.10M | 1237.30M |
| Reconciled depreciation | 104.70M | 90.40M | 84.90M | 80.90M | 73.00M |
| Ebit | 300.58M | 529.50M | 494.00M | 406.00M | 402.40M |
| Ebitda | 406.43M | 619.90M | 578.90M | 486.90M | 475.40M |
| Depreciation and amortization | 105.85M | 90.40M | 84.90M | 80.90M | 73.00M |
| Operating income | 300.58M | 406.10M | 475.00M | 406.00M | 402.40M |
| Other operating expenses | 2030.85M | 1937.00M | 1821.60M | 1624.20M | 1352.40M |
| Interest expense | 13.18M | 11.00M | 9.20M | 9.40M | 8.60M |
| Tax provision | 66.60M | 129.60M | 128.00M | 96.00M | 104.70M |
| Interest income | 10.20M | 11.70M | 19.00M | 16.50M | 2.40M |
| Net interest income | -3.00M | 0.70M | 9.80M | 7.10M | -6.20M |
| Income tax expense | 53.62M | 129.60M | 128.00M | 96.00M | 104.70M |
| Total revenue | 2331.43M | 2343.10M | 2235.60M | 1936.10M | 1648.30M |
| Total operating expenses | 1343.81M | 1321.80M | 1259.50M | 1136.20M | 941.40M |
| Cost of revenue | 687.04M | 615.20M | 562.10M | 488.00M | 411.00M |
| Total other income expense net | -99.86M | 112.40M | 9.80M | -3.30M | 31.10M |
| Net income from continuing ops | 147.30M | 388.90M | 356.80M | 300.60M | 289.10M |
| Net income applicable to common shares | - | - | - | 300.60M | 289.10M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 2599.25M | 2825.00M | 2745.10M | 2568.70M | 2465.10M |
| Intangible assets | 217.30M | 222.20M | 193.30M | 188.00M | 135.40M |
| Other current assets | 61.91M | 55.80M | 56.20M | 57.00M | 79.00M |
| Total liab | 861.19M | 874.70M | 904.60M | 819.90M | 779.40M |
| Total stockholder equity | 1738.06M | 1950.30M | 1840.50M | 1748.80M | 1685.70M |
| Deferred long term liab | - | - | - | - | 33.00M |
| Other current liab | 226.08M | 181.30M | 269.10M | 206.80M | 161.80M |
| Common stock | 1174.35M | 1176.00M | 1204.20M | 1250.30M | 1276.60M |
| Capital stock | 1176.00M | 1176.00M | 1204.20M | 1250.30M | 1276.60M |
| Retained earnings | 644.80M | 777.30M | 667.90M | 555.40M | 455.30M |
| Other liab | - | - | - | 79.30M | 76.60M |
| Good will | 265.23M | 278.60M | 257.70M | 256.10M | 257.10M |
| Other assets | - | - | - | 218.60M | 151.50M |
| Cash | 187.44M | 275.70M | 513.60M | 555.50M | 629.30M |
| Total current liabilities | 603.65M | 602.30M | 631.50M | 578.00M | 527.60M |
| Current deferred revenue | 65.41M | 80.40M | 66.70M | 61.60M | 54.70M |
| Net debt | 24.96M | -40.00M | -269.90M | -353.70M | -375.40M |
| Short term debt | 41.94M | 42.20M | 41.60M | 39.20M | 78.70M |
| Short long term debt | - | - | - | - | 42.60M |
| Short long term debt total | 212.40M | 235.70M | 243.70M | 201.80M | 253.90M |
| Other stockholder equity | -9.09M | - | - | -56.90M | -46.20M |
| Property plant equipment | - | - | - | 447.20M | 439.20M |
| Total current assets | 1298.38M | 1416.80M | 1452.10M | 1361.50M | 1327.00M |
| Long term investments | 41.10M | 78.90M | 83.40M | 97.30M | 119.10M |
| Net tangible assets | - | - | - | 1304.70M | 1326.20M |
| Short term investments | - | - | 4.80M | - | - |
| Net receivables | 558.42M | 585.90M | 490.70M | 437.50M | 348.50M |
| Inventory | 490.61M | 499.40M | 391.60M | 311.50M | 270.20M |
| Accounts payable | 270.22M | 298.40M | 303.20M | 270.40M | 232.40M |
| Accumulated other comprehensive income | -72.00M | -3.00M | -31.60M | -56.90M | -46.20M |
| Non currrent assets other | 11.50M | 123.60M | 143.50M | 93.30M | 71.20M |
| Non current assets total | 1300.87M | 1408.20M | 1293.00M | 1207.20M | 1138.10M |
| Capital lease obligations | 212.70M | 235.70M | 243.70M | 201.80M | 211.30M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | -13.80M | -115.20M | -105.70M | -125.70M | -61.70M |
| Change to liabilities | - | - | - | 31.80M | 89.80M |
| Total cashflows from investing activities | -104.35M | -115.20M | -105.70M | -125.70M | -138.90M |
| Net borrowings | 0.00M | - | - | -72.70M | -25.60M |
| Total cash from financing activities | -343.62M | -366.90M | -323.80M | -310.40M | -220.70M |
| Change to operating activities | - | - | - | 31.90M | 8.90M |
| Net income | 147.09M | 388.90M | 356.80M | 300.60M | 289.10M |
| Change in cash | -74.26M | -237.90M | -41.90M | -73.80M | 19.70M |
| Begin period cash flow | 261.70M | 513.60M | 555.50M | 629.30M | 609.60M |
| End period cash flow | 187.44M | 275.70M | 513.60M | 555.50M | 629.30M |
| Total cash from operating activities | 367.48M | 237.60M | 388.80M | 362.40M | 376.50M |
| Issuance of capital stock | - | 0.10M | 0.10M | - | 1.10M |
| Depreciation | 105.85M | - | 84.90M | 80.90M | 64.50M |
| Other cashflows from investing activities | - | -40.20M | -27.40M | - | - |
| Dividends paid | 280.81M | 278.20M | 245.70M | -197.40M | -194.00M |
| Change to inventory | 7.99M | - | -80.10M | -41.30M | -54.10M |
| Change to account receivables | 25.26M | - | -53.60M | -89.00M | -52.20M |
| Sale purchase of stock | -26.66M | -28.30M | -43.00M | -29.60M | -29.60M |
| Other cashflows from financing activities | -36.15M | -60.50M | -35.20M | -42.10M | -25.60M |
| Change to netincome | - | - | - | 23.30M | -7.60M |
| Capital expenditures | 61.01M | 102.60M | 89.80M | 95.90M | 77.20M |
| Change in working capital | -30.36M | - | -107.30M | - | - |
| Stock based compensation | - | - | 19.60M | - | - |
| Other non cash items | 144.90M | 237.60M | 496.10M | - | - |
| Free cash flow | 306.47M | 135.00M | 299.00M | 266.50M | 299.30M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CHEOF Cochlear Limited |
- -% |
92.00 | 60.07 | 26.18 | 2.69 | 5.07 | 3.81 | 26.97 |
| ABT Abbott Laboratories |
1.18 1.14% |
104.88 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
-0.62 0.65% |
94.79 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-1.02 0.33% |
306.13 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
0.84 1.83% |
46.97 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Diggory William Howitt BE (Hons), MBA | CEO, MD, Pres & Exec. Director | 1967 |
| Mr. Stuart Sayers | Chief Financial Officer | NA |
| Mr. Jan Janssen MSc Elec Eng | Chief Technology Officer | 1965 |
| Mr. Anthony Bishop | Pres of Asia Pacific & Latin America | NA |
| Ms. Lisa Aubert | Pres of North America | NA |
| Mr. Richard Brook MBA | Pres of EMEA | NA |
| Mr. David Hackshall | Chief Information Officer | NA |
| Ms. Kristina Devon | VP of Investor Relations | NA |
| Ms. Jennifer Stevenson | VP of Corp. Communications & Brand | NA |
| Mr. Dean Phizacklea | Sr. VP of Global Strategic Marketing | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.43%
Communication Services
-0.70%
Consumer Cyclical
-0.35%
Consumer Defensive
-0.54%
Energy
+0.40%
Financial Services
-0.54%
Financials
+0.30%
Healthcare
+0.19%
Industrials
+0.38%
Real Estate
+0.22%
Technology
+0.27%
Utilities
-0.53%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...